Attached files

file filename
8-K - 8-K - SPX CORPd884851d8k.htm

Exhibit 99.1

 

13320-A Ballantyne Corporate Place
Charlotte, NC 28277
Telephone: (980) 474-3700
Facsimile: (980) 474-3729
   LOGO
April 2, 2020

ADDENDUM TO PROXY STATEMENT

Following the printing of our 2020 Notice of Annual Meeting of Stockholders and Proxy Statement, we determined that numbers appearing in the second and fourth columns of the Equity Compensation Plan Information table appearing on page 42 were inadvertently transposed. The corrected table is as follows and replaces and supersedes the table appearing on page 42 of our 2020 Notice of Annual Meeting of Stockholders and Proxy Statement.

 

Plan Category

   Number of
Securities to Be
Issued Upon
Exercise of
Outstanding Options,
Warrants, and
Rights (a)(1)
     Weighted-Average
Exercise
Price of Outstanding
Options, Warrants,
and Rights (b)(2)
     Number of
Securities
Remaining Available
for Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in
Column (a))(3)
 

Equity Compensation Plans Approved By Stockholders

     2,296,954        19.05        4,943,874  
  

 

 

    

 

 

    

 

 

 

Total

     2,296,954        19.05        4,943,874  
  

 

 

    

 

 

    

 

 

 

 

(1)

Comprised of 1,691,343 shares issuable upon the exercise of outstanding Options and 605,611 shares issuable pursuant to RSUs and PSUs.

(2)

Excludes RSUs and PSUs.

(3)

All these shares were available for issuance under the 2019 Stock Compensation Plan.